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Abstract
Background: Patient education is an essential component in quality management of the anticoagulated
patient. Because it is time consuming for clinicians and overwhelming for patients, education of the
anticoagulated patient is often neglected. We surveyed the medical literature in order to identify the best
patient education strategies.
Methods: Study Selection: Two reviewers independently searched the MEDLINE and Google Scholar
databases (last search March 2007) using the terms "warfarin" or "anticoagulation", and "patient
education". The initial search identified 206 citations, A total of 166 citations were excluded because
patients were of pediatric age (4), the article was not related to patient education (48), did not contain
original data or inadequate program description (141), was focused solely on patient self-testing (1), was
a duplicate citation (3), the article was judged otherwise irrelevant (44), or no abstract was available (25).
Data Extraction: Clinical setting, study design, group size, content source, time and personnel involved,
educational strategy and domains, measures of knowledge retention.
Results: Data Synthesis: A total of 32 articles were ultimately used for data extraction. Thirteen articles
adequately described features of the educational strategy. Five programs used a nurse or pharmacist, 4
used a physician, and 2 studies used other personnel/vehicles (lay educators (1), videotapes (1)). The
duration of the educational intervention ranged from 1 to 10 sessions. Patient group size most often
averaged 3 to 5 patients but ranged from as low as 1 patient to as much as 11 patients. Although 12 articles
offered information about education content, the wording and lack of detail in the description made it too
difficult to accurately assign categories of education topics and to compare articles with one another. For
the 17 articles that reported measures of patient knowledge, 5 of the 17 sites where the surveys were
administered were located in anticoagulation clinics/centers. The number of questions ranged from as few
as 4 to as many as 28, and questions were most often of multiple choice format. Three were self-
administered, and 2 were completed over the telephone. Two reports described instruments along with
formal testing of the validity and reliability of the instrument.
Conclusion: Published reports of patient education related to warfarin anticoagulation vary greatly in
strategy, content, and patient testing. Prioritizing the educational domains, standardizing the educational
content, and delivering the content more efficiently will be necessary to improve the quality of
anticoagulation with warfarin.
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Background
Warfarin is a dangerous outpatient medication, by any-
one's estimation. It is the second most common cause of
adverse drug events in emergency rooms, and the overall
risk of major bleeding averages 7–8% per year [1,2].
Despite the risk, well-established indications for warfarin
are increasing in prevalence with aging of the population
[3,4], and new indications for warfarin are regularly rec-
ommended [5,6]. As a result, the proportion of elderly
persons taking warfarin has risen to as high as 7% [7].
Increasing a patient's understanding about warfarin is a
logical goal. Prior knowledge about warfarin has been
associated with a decreased risk of bleeding [8]. Written
and verbal information has been shown to improve con-
trol of the level of anticoagulation [9]. While past studies
suggest that patient education may be associated with bet-
ter clinical outcomes, doubts remain about the effective-
ness of patient education strategies [10-12]. As a result,
systematic patient education regarding long-term warfarin
is not universally implemented.
Our objectives were to (1) identify the published strate-
gies (duration, timing, personnel requirements, content
domains) for patient education regarding warfarin antico-
agulation and (2) identify published instruments for
measuring patient knowledge.
Methods
In March 2007, we searched MEDLINE using the MESH
terms ("warfarin" or "anticoagulation") AND "patient
education". We limited our search to articles published in
the English language. We used the related articles link in
PubMed and searched the references of identified cita-
tions for additional original articles. Similar search terms
were used to search Google Scholar. As warfarin is by far
the most commonly used oral anticoagulant, we did not
seek articles related to other oral anticoagulants.
We sought articles that (a) were original research studies
or descriptions of patient education programs that
included information on the educational content and
strategy related to anticoagulation with warfarin, or (b)
contained instruments that measured patient knowledge.
Exclusion criteria included studies conducted in pediatric
populations, unrelated to patient education, lacking orig-
inal data or an adequate program description, and those
in which the educational effort was focused solely on
patient self-testing. Because citations might be excluded
for multiple reasons, we used this above mentioned
sequence for excluding citations.
An initial search identified 206 citations. Two reviewers
(JLW, MDW) reviewed titles and available abstracts to
determine relevance to the stated objectives of identifying
(1) the optimal educational content and delivery (dura-
tion, timing, personnel requirements), and (2) the opti-
mal strategies for measuring patient knowledge. Full text
articles were retrieved for citations that met our inclusion
criteria and for those where inclusion/exclusion criteria
were not determinable by the title and abstract. Two other
citations were encountered during the process of review-
ing articles that were deemed eligible, raising the number
of eligible articles to 208.
A total of 154 citations were initially excluded because
patients were of pediatric age (1.9%, 4), the article was not
related to patient education (23.1%, 48), did not contain
original data or inadequate program description (18.8%,
39), was focused solely on patient self-testing (1), was a
duplicate citation (1.4%, 3), or the article was judged oth-
erwise irrelevant (16.8%, 35), or no abstract was available
(11.5%, 24) (Figure 1).
After exclusions, a total of 44 articles qualified for further
review. Upon further review, an additional 12 articles
were excluded because of inadequate program descrip-
tion, ultimately leaving a total of 32 articles for data
extraction (Figure 1). We extracted data on clinical setting,
study design, group size, content source, time and person-
nel involved; and created summary tables. Two reviewers
(MDW, JLW) identified the educational topics covered in
these reports. Among studies that tested patient knowl-
edge, we extracted information on setting and study pop-
ulation, number and type of questions, and method of
administration.
Search strategy for studies and programs related to patient  education about warfarin anticoagulation Figure 1
Search strategy for studies and programs related to patient 
education about warfarin anticoagulation.
208 citations identiﬁed by 
initial electronic search
44 articles qualiﬁed for 
further review
154 citations excluded 
12 articles not used
32 articles for data extraction
13 related to strategy
12 related to content
17 related to knowledge testingBMC Health Services Research 2008, 8:40 http://www.biomedcentral.com/1472-6963/8/40
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Results
Thirteen articles had a description of the research methods
or program that was adequate and consistent with our
objectives of identifying the duration, timing and setting,
and personnel requirements of the educational program
(Table 1) [13-25]. Five programs used a nurse or pharma-
cist (45%), four used a physician, and two studies used
other personnel/vehicles (lay educators (1), videotapes
(1)). The duration of the educational intervention ranged
from one to ten sessions. Patient group size most often
averaged three to five patients but ranged from as low as
one patient to as much as eleven patients. While the
majority of the educational efforts occurred in inpatient
settings, most seemed relevant to contemporary outpa-
tient settings.
Although twelve articles offered information about educa-
tion content, the wording and lack of detail in the descrip-
tion made it too difficult to accurately assign categories of
education topics and to compare articles with one another
[2,11,12,15,19,22-24,26-29]. Nevertheless, we summa-
rized the categories suggested by these studies and listed
the potential topics for each category (Table 2).
Relevant to our objective of identifying measures of
patient knowledge, Table 3 shows the seventeen relevant
citations [9,11,12,15,18,24,30-40]. Five of the seventeen
sites where the surveys were administered were located in
anticoagulation clinics/centers. The number of patients
included in these studies ranged from as low as 22 to as
high as 530. The number of questions ranged from as few
as 4 to as many as 28 questions, and were most often of
multiple choice format. Three were self-administered, and
two were completed over the telephone. Two citations
[12,32] described testing instruments along with formal
testing of the validity and reliability of the instrument.
Discussion
Patient education has long been thought to be useful for
patients receiving long-term anticoagulation. Proposals
have been periodically issued suggesting the content of
the educational task [2,23,41]. However, inadequate
attention to health education principles and educational
program design have more often been the problem than
have issues of content [29,42]. Despite the practical value
of making the patient as knowledgeable as possible, the
best strategy for educating patients about anticoagulation
is yet to be determined [10].
The variety of strategies shown in Table 1 likely reflect a
varying amount of support and resources devoted to this
patient education goal. Delegating these educational
activities to midlevel practitioners, pharmacists, or desig-
nated nurses are strategies well supported by the our liter-
ature review. However, in any given clinical setting, local
factors such reimbursement and available manpower may
determine which health professional(s) is best responsi-
ble for managing a population of anticoagulated patients.
The advent of warfarin self-monitoring with home coagu-
lometers has sparked renewed interest in improving
patient education related to anticoagulation [2,13]. Gov-
ernment-supported efforts in Germany and Netherlands
now devote a significant level of time and manpower to
this educational task [21,43]. However, most clinical set-
tings in the U.S. and elsewhere, may not be able to match
that level of support [15]. Because most anticoagulation
management still takes place in the offices of clinicians
[44,45], strategies to provide education should be relevant
to all clinical settings.
We also found much variability in the content areas
reported by educational programs, to the degree that we
could not accurately categorize educational domains, let
alone make fair comparisons among programs. Some
issues (manifestations of bleeding, INR monitoring, etc)
were a component of most educational programs, while
other issues (Vitamin K, pill color) were present only in a
few. Our inability to summarize published efforts likely
reflects an underreporting of details rather than extreme
variability among programs. Nevertheless, our table of
potential educational topics (Table 2) reflects a daunting
agenda.
The testing of patient knowledge regarding warfarin and
anticoagulation used a variety of instruments. Only two of
the sixteen instruments – the Oral Anticoagulation
Knowledge (OAK) instrument and the Anticoagulation
Knowledge Assessment (AKA) – have been subject to any
formal evaluation. The Oral Anticoagulation Knowledge
(OAK) investigators evaluated construct and content
validity, test-retest reliability, and internal consistency
reliability [12]. The Anticoagulation Knowledge Assess-
ment (AKA) investigators used the Rasch model in order
to examine validity, and item and person reliability [32].
Both the OAK and AKA are reported to be written at the
7th grade reading level, but neither instrument has been
validated in other clinical settings. The best strategy for
measuring patient knowledge would depend, in part, on
the content of the educational program, but standardiza-
tion of the testing effort should be a realistic goal.
The limitations of our study deserve acknowledgement.
While our study reflected a variety of different strategies
for all aspects of the educational process, it is probable
that noteworthy and innovative patient education efforts
may not be reflected in the medical literature. Second, in
reviewing these reports, it is often difficult to separate the
management strategy from the educational strategy.B
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Table 1: Patient Education Strategies Related to Warfarin and Anticoagulation
Citation Location Study Design Stated Goal Group Size Personnel involved Strategy/Duration/Frequency
Menendez-Jandula et al13 2005 Barcelona, 
Spain RCT
To prove the value of self-
management on INR control and 
clinical outcomes
5–8 patients and option of having 
family member present
Specially trained nurse 2 sessions of 2 hours on consecutive 
days Based on German model
Koertke et al14 20051 Westphalia, Germany 
Program description
To describe the principles of a 
training course to learn INR self-
management
Not more than 5 patients Not stated Welcome period Two phase 
(hospital, 6 months later) Average 
duration 3–4 hours (1.5 for 
theoretical and 1.5 for device 
handling)
Voller et al15 20041 Westphalia, Germany 
Program description
To evaluate the effects of a training 
program on patient knowledge
2–5 patients Not stated Two half day sessions 2–7 days 
apart. Patient logbook
Khan et al16 2004 Newcastle, U.K. RCT To prove the value of education and 
self-monitoring on INR control and 
quality of life
2–3 patients Led by physician 1 two hour educational session
Gadisseur et al17 2003 Leiden, Netherlands 
RCT
To examine effects of self-
management on quality of life
4–5 patients Specialized teams of physicians and 
nurses
3 weekly sessions of 90–120 
minutes
Singla et al18 2003 Philadelphia, U.S. Cohort 
Survey
To examine effects of group 
education on knowledge
11 persons Pharmacist or nurse 1 one hour session
Amruso19 2003 Tampa, U.S. Program 
description
To examine effects of group 
education on knowledge
One-on-one Chain pharmacy pharmacist Ongoing monthly appointments
Beyth et al20 2000 San Francisco, U.S. RCT To prove the value of self-
management
One-on-one Lay educator Specifically formatted workbook. 
Coaching on communication skills. 
Self monitoring
Morsdorf et al21 1999 Saarland, Germany 
Program description
To examine the efficiency of patient 
training for self-management
4–6 patients Single MD\Single instructor 4 theoretical and 2–6 practical 
sessions Video assisted 
demonstrations
Foss et al22 1999 Denver, U.S. Program 
description
To describe the efficiencies of a 
high-volume anticoagulation clinic
Not more than 6 patients Pharm D 1 hour slide presentation
Sawicki et al23 1999 Dusseldorf, Germany 
RCT
To prove effect of self management 
on accuracy of control and quality of 
life
3–6 patients Physicians and nurses 3 consecutive weekly teaching 
sessions of 60 to 90 minutes in 
duration
Stone et al24 1989 Worcester, U.S. RCT To examine the effect of videotape 
on knowledge
One-on-one Nurse 15 minute videotape compared with 
25 minute nurse lecture
Scalley et al25 1979 San Antonio, U.S. 
Program description
To develop a program for patient 
education
One-on-one Pharmacist or nurse Average 30 minutes. Slide 
presentation and booklet. Checklist 
of learning objectives placed in 
patient's chartBMC Health Services Research 2008, 8:40 http://www.biomedcentral.com/1472-6963/8/40
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Despite the variability in the content and strategies of edu-
cational programs, several important issues should drive
future efforts at patient education, in our opinion. Educa-
tional programs should focus on topics essential for
patient safety, such as what to do when INR is high, rather
than the minute details of anticoagulation that overbur-
den the patient. Second, these programs would best be
implemented with measures of effectiveness and
improvement in patient knowledge, adherence and out-
comes using validated instruments. Lastly, educational
programs should attempt to maximize office efficiency by
delegating this task to physician extenders, nurses, phar-
macists, or perhaps an office-based computer.
Conclusion
Patient education is entering a new era where accountabil-
ity in educational outcomes, interest in literacy/language
barriers, and the importance of cost-effectiveness will
influence the process of patient education. Prioritizing the
educational content and using validated instruments for
measuring the outcomes of patient education will be a
necessary first step in improving anticoagulation out-
comes. This systematic review should guide future efforts.
Table 2: Topics for Education of the Anticoagulated Patient
Category Educational Topic
Basics of anticoagulation
Description of the coagulation system
Normal blood clotting compared with clotting of an anticoagulated patient
Warfarin – mechanism
Risk-Benefit
Risk of bleeding versus – descriptive versus numerical
Risk of clotting – descriptive versus numerical
Complications of thromboemboli
Adherence
Color and strength of tablets
What to do if dose missed
Accessing healthcare professionals
When to call the doctor
When to seek emergency care
Anticoagulation services
Diet
Basics of Vitamin K
Specific foods
Lab monitoring
Basics of the INR
Therapeutic INR range
Most recent INR Result
Interpretation of INR values
Frequency of INR determination
Medication interactions
Antibiotics
OTC medications
Self-Care
Injury management and contraindicated activities
Signs of bleeding events (overdose)
Signs of thromboembolic events (underdose)
Management of minor bleeding events
Medical alert bracelet
Special situations – illness, travel, pregnancy, surgeries
Endocarditis prophylaxis
Self-testing
Dose adjustment
Home coagulometry
Diary/quality control record keepingB
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Table 3: Studies Testing Patient Knowledge Regarding Anticoagulation
Citation Setting/Study population Questions – Number and Type Administration
Hu et al30 2006 Large urban teaching hospital 100 mechanical valve 
patients
20, True-False Scripted telephone survey Trained medical student
Zeolla et al12 2006 OAK test U.S., Recruited from 4 pharmacies and 2 clinics 122 
volunteers
20, Multiple choice, Validity and reliability testing Self administered Excluded illiterate patients 7th grade 
reading level
Roche-Nagle, Chambers31 2006 Dublin teaching hospital anticoagulation clinic 150 
consecutive patients
8, Specific answers Standardized interview
Davis et al11 2005 Two NYC anticoagulation clinics 52 patients 18, Multiple choice Self administered Single visit Excluded low literacy 
patients
Briggs et al32 2005 AKA test Two Chicago inner city, pharmacist-managed 
anticoagulation clinics 60 patients
28, Multiple choice, Validity and reliability testing Self administered Excluded illiterate patients 7th grade 
reading level
Voller et al15 2004 Three German 3 teaching centers 76 patients 13, Multiple choice Questions not available
Nadar et al33 2003 3 U.K. teaching hospital anticoagulation clinics 180 
patients who attended the clinic > 5 times
9, Short answer Language concordance, personal interview
Tang et al9 2003 1 Hong Kong anticoagulation clinic 56 patients 
months postdischarge
9, Dichotomous and open-ended 2 rehearsed pharmacy students Leading questions 
avoided Scoring details
Cheah et al34 2003 U.S. teaching hospital center 50 inpatients 10, Open-ended Telephone survey
Singla et al18 2003 U.S. anticoagulation center 180 patients 4, Yes/No Immediately after class
Wilson et al35 2003 U.S. urban university hospital anticoagulation clinic 65 
patients
20, Short answer Investigator interview one week post discharge. 
Instrument not available
Barcellona et al36 2002 Italian thrombosis center 216 patients taking warfarin 
for 6 months
6, Multiple choice Self-administered
Waterman et al37 2001 U.S. managed care organization 530 patients 11, True-False or short answer Telephone-based interview at enrollment
Wyness et al38 1990 U.S. university hospital vascular surgery unit 23 
patients
Interview soliciting explanation Before discharge, and 1 & 3 months after discharge 
Oral interview
Stone et al24 1989 Hospital-based anticoagulation clinic 22 patients 18, True-False Self-administered
Rankin39 1979 University hospital cardiac rehabilitation unit 19 
patients
14, Multiple choice 3–4 days later and 3 weeks later Investigator 
administered
Clark et al40 1972 U.S. university hospital, 45 patients 15, Multiple choice Self administeredBMC Health Services Research 2008, 8:40 http://www.biomedcentral.com/1472-6963/8/40
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